COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines. Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than […]
Oxford researchers have used analysis of T-cell populations to identify new therapeutic opportunities in pancreatic cancer patients. Pancreatic cancer has one of the worst prognoses of any cancer, with pancreatic ductal adenocarcinoma (PDAC) patients having an average survival rate of 7%. T-cells (the lymphocytes that play a wide range of roles in shaping the body’s immune response […]
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. Early treatment with inhaled budesonide shortens recovery time by a median of three days in […]
One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders. Professor Paul Harrison, lead author of the study, […]
A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability. Many people recovering from COVID-19 suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and […]
Oxford Brookes University’s successful work in commercialising its intellectual property (IP), predominantly through IP licensing but also through spinouts, has been ranked in the top 10% of English universities in the first Knowledge Exchange Framework results published today [Wednesday 31 March] by Research England. Oxford Brookes was placed in the top 40% for its research […]
Bereaved relatives described the ongoing pain of being absent at the end of a loved-one’s life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care. The first paper to give voice to those bereaved during the pandemic is […]
Professor Gary Ford, Chief Executive of the Oxford Academic Health Science Network and consultant stroke physician at OUH, is the new Chair of the AHSN Network, the national body bringing together England’s 15 AHSNs. Gary said: “I am delighted to be taking on this role at an important time for AHSNs and the wider NHS. […]
A project set to be the world’s largest study into the effects of exercise on the successful treatment of children with cancer has begun, with scientists from Oxford Brookes University taking a leading role. The five and a half year project, named FORTEe, has received €6.2 million (£5.4 million) funding from the EU Horizon programme and involves 16 […]
Medical research into eye genetics at Oxford Brookes University has received a funding pledge of £2 million from Baillie Gifford, an international investment business. The gift supports the work of Professor Nicola Ragge who has spearheaded a national eye genetics service, leading world-leading research into eye development problems in children. Specialising in cases where babies are […]